
Pulmatrix, Inc.
PULMHealthcare|Biotechnology|US
$1.38
-0.02 (-1.43%)
DCF Value
$1.05
Tangible Book / Share
$0.70
Cash / Share
$0.59
Next Earnings Report
Apr 1, 2027
EPS est. -$1.40 · Revenue est. $2.5M
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Oct 26, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study
Oct 30, 2026 · GlobeNewsWire
Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse
Oct 22, 2026 · GlobeNewsWire
Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
Sep 22, 2026 · GlobeNewsWire
Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger
Aug 13, 2026 · PRNewsWire
SEC Filings (57)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 30, 2026 | 425 | DocumentIndex | |
| Oct 27, 2026 | 8-K | Material event | DocumentIndex |
| Oct 26, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 22, 2026 | EFFECT | DocumentIndex | |
| Oct 22, 2026 | 425 | DocumentIndex | |
| Oct 13, 2026 | 425 | DocumentIndex | |
| Oct 7, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 7, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Oct 5, 2026 | ARS | Annual report to holders | DocumentIndex |
| Oct 5, 2026 | S-3/A | Shelf registration | DocumentIndex |
| Sep 25, 2026 | EFFECT | DocumentIndex | |
| Sep 25, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 25, 2026 | DEFM14A | Proxy / shareholder vote | DocumentIndex |
| Sep 23, 2026 | S-4/A | DocumentIndex | |
| Sep 22, 2026 | 425 | DocumentIndex | |
| Sep 17, 2026 | S-4/A | DocumentIndex | |
| Sep 4, 2026 | S-4/A | DocumentIndex | |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Aug 7, 2026 | S-3/A | Shelf registration | DocumentIndex |
| Aug 3, 2026 | S-4/A | DocumentIndex | |
| Jul 9, 2026 | S-4 | DocumentIndex | |
| Jun 16, 2026 | 10-K/A | Annual report | DocumentIndex |
| Jun 5, 2026 | 425 | DocumentIndex | |
| Jun 4, 2026 | S-3 | Shelf registration | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 15, 2026 | 8-K | Material event | DocumentIndex |
| Apr 22, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Apr 21, 2026 | 8-K | Material event | DocumentIndex |
| Apr 15, 2026 | D | DocumentIndex | |
| Mar 27, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | 425 | DocumentIndex | |
| Mar 2, 2026 | 8-K | Material event | DocumentIndex |
| Feb 26, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 26, 2026 | 8-K | Material event | DocumentIndex |
| Dec 18, 2025 | 8-K | Material event | DocumentIndex |
| Oct 16, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 16, 2025 | 8-K | Material event | DocumentIndex |
| Aug 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2025 | 8-K | Material event | DocumentIndex |